Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 19 Breast Neoplasms 18 Leukemia, Myeloid, Acute 9 Ovarian Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Lung Neoplasms 5 Stomach Neoplasms 4 Leukemia 4 Fatigue 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2

Interventions

Surveys and Questionnaires 7 Standard of Care 5 Sirolimus 5 Bevacizumab 5 temsirolimus 4 Interviews as Topic 4 Paclitaxel 3 olaparib 2 Vorinostat 2 Olanzapine 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Everolimus 2 Erlotinib Hydrochloride 2 Dasatinib 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olanzapine-fluoxetine combination 1 nimotuzumab 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Palliative Care × Clear all

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡